Dr. Ibrahim - Advances in Cutaneous Squamous Cell Carcinoma

Dr. Rischin Discusses Cemiplimab in Cutaneous Squamous Cell CarcinomaПодробнее

How Patients With Advanced/Metastatic CSCC PresentПодробнее

Squamous Cell Carcinoma and Lentigo Maligna Melanoma: plus the pre-cancerous conditions:Подробнее

Dr. Postow on FDA Approval of Cemiplimab in Metastatic Cutaneous Squamous Cell CarcinomaПодробнее

Dr. Hyams - 40 GEP Cutaneous Squamous Cell CarcinomaПодробнее

Core outcome set for cutaneous squamous cell carcinoma, K.A. Reynolds et alПодробнее

Dr. Goldberg - Diagnostic & Prognostic Testing in Melanoma and Cutaneous Squamous Cell CarcinomaПодробнее

Dr. Moody - Advances in Cutaneous MelanomaПодробнее

Advances in the Diagnosis and Treatment of SCC and BCCПодробнее

Elucidating a Case of Locally Advanced CSCCПодробнее

Dr. Atlas on the Rationale for Cemiplimab in Locally Advanced CSCCПодробнее

Surgery Versus Immunotherapy in CSCCПодробнее

Skin Cancer Development Time Lapse (Normal to Squamous Cell Carcinoma Over 25 Years)Подробнее

Updates to the Treatment Landscape of Cutaneous Squamous Cell CarcinomaПодробнее

Multidisciplinary Advanced Cutaneous Squamous Cell Carcinoma Care WebinarПодробнее

Standard-of-care and future research directions for advanced squamous cell carcinomaПодробнее

MATISSE: nivolumab in cutaneous squamous cell carcinomaПодробнее

Neoadjuvant atezolizumab for advanced cutaneous squamous cell carcinomaПодробнее

Merkel Cell Carcinoma Development Time Lapse - More Deadly Than Melanoma!Подробнее

Advanced CSCC: The New Systemic TherapyПодробнее